TTY Biopharm Co (ROCO:4105) Dividend Payout Ratio: 2.59 (As of Mar. 2026) — 250% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4105 TTY Biopharm Co Ltd ROCO:4105
83 GF Score
Price NT$78.10
GF Value NT$87.56
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is TTY Biopharm Co Dividend Payout Ratio?

TTY Biopharm Co ROCO:4105 +0.39% 83 Dividend Payout Ratio is 2.59 as of Mar. 2026, which is 250% above its 10-year median of 0.74. GuruFocus rates ROCO:4105 with a GF Score™ of 83/100 and a GF Value™ of NT$87.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 445 Drug Manufacturers companies, TTY Biopharm Co ranks worse than 81.35% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. TTY Biopharm Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 2.59.

The historical rank and industry rank for TTY Biopharm Co's Dividend Payout Ratio or its related term are showing as below:

ROCO:4105' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.61   Med: 0.74   Max: 1.25
Current: 0.7

During the past 13 years, the highest Dividend Payout Ratio of TTY Biopharm Co was 1.25. The lowest was 0.61. And the median was 0.74.

ROCO:4105's Dividend Payout Ratio is ranked worse than
81.35% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs ROCO:4105: 0.70

As of today (2026-07-21), the Dividend Yield % of TTY Biopharm Co is 5.76%.

During the past 13 years, the highest Trailing Annual Dividend Yield of TTY Biopharm Co was 9.85%. The lowest was 2.62%. And the median was 5.33%.

TTY Biopharm Co's Dividends per Share for the months ended in Mar. 2026 was NT$4.50.

During the past 12 months, TTY Biopharm Co's average Dividends Per Share Growth Rate was 7.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 11.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -0.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of TTY Biopharm Co was 129.10% per year. The lowest was -31.00% per year. And the median was 6.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

TTY Biopharm Co (ROCO:4105) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

TTY Biopharm Co Dividend Payout Ratio Related Terms

TTY Biopharm Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for TTY Biopharm Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTY Biopharm Co Dividend Payout Ratio Chart

TTY Biopharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 0.68 0.76 0.61 0.68

TTY Biopharm Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.74 0.00 0.00 0.00 2.59

ROCO:4105 vs ZTS, UTHR: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TTY Biopharm Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Dividend Payout Ratio falls into.


ROCO:4105
83GF Score
TTY Biopharm Co Ltd ROCO:4105
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTY Biopharm Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

TTY Biopharm Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=4.2/ 6.225
=0.67

TTY Biopharm Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=4.5/ 1.737
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 2.59 mean?
TTY Biopharm Co (ROCO:4105) has a Dividend Payout Ratio of 2.59 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on TTY Biopharm Co and its competitors. This is 250% above median its historical median of 0.74. Over the past decade, TTY Biopharm Co's Dividend Payout Ratio has ranged from 0.61 to 1.25. According to the industry distribution chart, TTY Biopharm Co ranks #362 out of 445 companies in the Drug Manufacturers industry, placing it in the top 81.3%.
Is TTY Biopharm Co's Dividend Payout Ratio too high?
TTY Biopharm Co's current Dividend Payout Ratio of 2.59 is 250% above median its 10-year median of 0.74. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 1.25. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. TTY Biopharm Co's value of 2.59 is 581.6% above this industry median. Based on the distribution chart, TTY Biopharm Co ranks #362 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, TTY Biopharm Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTY Biopharm Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, TTY Biopharm Co ranks #362 out of 445 companies for Dividend Payout Ratio. This places TTY Biopharm Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. TTY Biopharm Co's value of 2.59 is 581.6% above this benchmark. Historically, TTY Biopharm Co's own Dividend Payout Ratio has ranged from 0.61 to 1.25 over the past decade. While the company's 10-year median is 0.74 vs. the industry median of 0.38, TTY Biopharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTY Biopharm Co's current Dividend Payout Ratio of 2.59 is 581.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on TTY Biopharm Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTY Biopharm Co's current Dividend Payout Ratio is 2.59, which is 250% above median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTY Biopharm Co stock overvalued right now?
Based on GuruFocus' analysis, TTY Biopharm Co (ROCO:4105) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.56, compared to a current price of NT$78.10 — trading 10.8% below its estimated fair value. The current Dividend Payout Ratio is 2.59, which is 250% above median its 10-year median of 0.74 and 581.6% above the Drug Manufacturers industry median of 0.38. TTY Biopharm Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For TTY Biopharm Co (ROCO:4105), the current Dividend Payout Ratio is 2.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTY Biopharm Co (ROCO:4105) Overvalued in 2026?

Based on GuruFocus' analysis, TTY Biopharm Co stock appears to be undervalued. The current stock price of NT$78.10 is trading 10.8% below its estimated GF Value™ of NT$87.56. GuruFocus considers TTY Biopharm Co to be Modestly Undervalued.

Key valuation signals for ROCO:4105:

  • Dividend Payout Ratio: 2.59 (250% above median its 10-year median of 0.74)
  • GF Value™: NT$87.56 vs. price of NT$78.10 (10.8% below fair value)
  • GF Score™: 83/100 with 1 warning sign
  • Industry Position: 581.6% above the Drug Manufacturers median (#362 of 445)

No single metric tells the full story. See the ROCO:4105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TTY Biopharm Co Business Description

Address No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in America. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.
83GF Score

Get the complete analysis for ROCO:4105

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$78.10
Price
NT$87.56
GF Value